The North America molecular biology enzymes, reagents, and kits market size was estimated at USD 650.00 million in 2025 and is projected to be worth around USD 1,596.20 million by 2035, is expanding at a CAGR of 9.40% from 2026 to 2035. The market is expected to grow with the help of factors such as growing R&D, high-throughput sequencing, PCR, precision medicine, biobanking, and clinical diagnostics demand.

North America Molecular Biology Enzymes Reagents and Kits Market Statical Scope

The North America molecular biology enzymes, reagents, and kits market is also expected to grow with the help of factors such as heavy investment in biology and pharmaceutical R&D, growing prevalence of chronic diseases, advancements in gene editing , and higher funding for genomic research. The growing shift of the market towards automation-friendly kits and reagents also propels the growth of the market.

North America Molecular Biology Enzymes, Reagents, and Kits Market, By Product, 2025

• Kits and Reagents- The kits and reagents segments dominated the market with 68% of the market share in 2025. The segment's demand is majorly propelled by factors such as higher demand for optimized and reproducible workflows in PCR, DNA sequencing, and diagnostic testing. The segment is also inclusive of DNA/RNA extraction kits, PCR master mixes, and cloning kits.
• Enzymes- The segment is observed to grow with 32% of the market share and is mainly driven by its various applications for polymerases, ligases, and restriction enzymes. Its increasing application in amplification, sequencing, and cloning technologies also helps to fuel the growth of the market.

North America Molecular Biology Enzymes, Reagents, and Kits Market, By Application, 2025

• PCR- The PCR segment dominated the global market with 25% of the market share in 2025. The segment's growth is propelled by rising infectious disease diagnostics, cancer detection, and academic research. Increasing usage of the technology in hospitals and diagnostic centers for pathogen surveillance also propels the growth of the segment.
• Sequencing- The segment is observed to grow with a notable 16% of the market share and is driven by factors such as its widespread application in clinical diagnostics, personalized medicine, and pharmaceutical R&D. Rapid advancements in NGS technologies and propelling investments in biotech and pharmaceutical research are also elevating the market's demand.
• Cloning- The segment accounts for 12% of the market share and is driven by factors such as advancements in gene editing, synthetic biology, and growing demand for recombinant proteins. Cloning, being the central element to developing gene therapy vectors in various North American institutes, also helps to fuel the growth of the market.

North America Molecular Biology Enzymes, Reagents, and Kits Market, By End Use, 2025

• Pharma and Biotech- The segment dominated the market with 46% of the market share, with rapid advancements in drug discovery, synthetic biology, and biopharmaceutical production. Growing investment in personalized medicine, growing prevalence of chronic diseases, along with expanding biomanufacturing capabilities, also fuel the segment's growth.
• Academic and Research- The segment accounts for 31% of the market share, driven by a strong focus of the segment on genomics and biotechnology. The growing demand for molecular diagnostics and the propelling CRO industry also help to fuel the growth of the market.

Top Companies in the North America Molecular Biology Enzymes, Reagents, and Kits Market

• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• QIAGEN
• Promega Corporation
• New England Biolabs
• Merck KGaA
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Takara Bio, Inc.
• LGC Limited

Segments Covered in the Report

By Product

• Kits and Reagents
• Enzymes

By Application

• PCR
• Sequencing
• Cloning
• Epigenetics
• Genotyping
• RCA/MDA
• RNA Therapeutics
• Transcriptomics
• Proteomics
• Liquid Biopsy
• Other Applications

By End-use

• Pharma & Biotech
• Academic & Research
• Hospital & Diagnostics
• Others